news tirzepatide cuts risk of diabetes by 94% in adults with prediabetes and obesity or overweight, drugmaker says tirzepatide news today recency:3 ✨

Baird, Donna Day, et al

Tirzepatide 10mg Research-grade Tirzepatide, a synthetic dual GLP-1/GIP receptor agonist peptide studied for metabolic and glucose homeostasis research

The category has attracted the highest number of new customers that weve seen in several years, driving a more than 30% increase in sales. To better serve these shoppers, Weve completely remerchandised the weight management section across our stores, grouping products by clear goals and objectives to ensure you can quickly identify the solutions that align with your health journey, Butera says

Lastly, Fig

Phase 2 trials (Jastreboff et al., NEJM, 2023) have shown it to be highly effective for weight reduction in adults with obesity